MUSTANG BIO, INC. Notes Assumed
MUSTANG BIO, INC. (MBIO) reported Notes Assumed of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-29.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:NotesAssumed1 · last filed 2018-03-29
- MUSTANG BIO, INC. notes assumed for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- MUSTANG BIO, INC. notes assumed for fiscal 2016 was $3.47M.
| Period end | Notes Assumed 10 month | Notes Assumed 12 month |
|---|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-03-29 | |
| 2016-12-31 | $3.47M 10-K · filed 2018-03-29 | |
| 2015-12-31 | $0.00 10-K · filed 2018-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |